share_log

HC Wainwright Reiterates Buy Rating, $79 Price Target On TG Therapeutics

Benzinga Real-time News ·  Mar 3, 2021 00:50
HC Wainwright Reiterates Buy Rating, $79 Price Target On TG Therapeutics
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment